Business Description
VentriPoint Diagnostics Ltd
NAICS : 621510
SIC : 8633
ISIN : CA92281P2008
Description
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its flagship product, the Ventripoint Medical System (VMS+), transforms standard 2D and 3D echocardiography and MRI images into accurate three-dimensional heart models and volumetric measurements, enabling clinicians to assess disease severity, track progression, evaluate treatment response, and guide surgical and pharmacological decisions. Additionally, the company has developed VMS+ 3D Echo and MRI software that can be installed on any personal workstation to create a 3D model of the heart's chamber. Geographically, its products are sold in Canada and internationally.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | -8.72 | |||||
Debt-to-Equity | -0.63 | |||||
Debt-to-EBITDA | -0.98 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -208.97 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 19.8 | |||||
3-Year EPS without NRI Growth Rate | 12.6 | |||||
3-Year FCF Growth Rate | 30.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 26.26 | |||||
9-Day RSI | 33.78 | |||||
14-Day RSI | 39.07 | |||||
3-1 Month Momentum % | 21.52 | |||||
6-1 Month Momentum % | 13.18 | |||||
12-1 Month Momentum % | 1.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.08 | |||||
Quick Ratio | 0.08 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 44.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.6 | |||||
Shareholder Yield % | -5.19 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -1899.44 | |||||
Net Margin % | -1788.27 | |||||
EBITDA Margin % | -1489.94 | |||||
FCF Margin % | -882.68 | |||||
OCF Margin % | -882.68 | |||||
ROA % | -548.12 | |||||
ROIC % | -155.19 | |||||
3-Year ROIIC % | 65.35 | |||||
ROC (Joel Greenblatt) % | -1780.03 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 110.1 | |||||
EV-to-EBIT | -7.98 | |||||
EV-to-EBITDA | -8.16 | |||||
EV-to-Revenue | 123.12 | |||||
EV-to-FCF | -13.95 | |||||
Earnings Yield (Greenblatt) % | -12.53 | |||||
FCF Yield % | -8.1 |
GF Valueâ„¢
VentriPoint Diagnostics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
VentriPoint Diagnostics Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2015-12-07 | 0.19 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:VPTDF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on VentriPoint Diagnostics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers